Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 149

1.

Expression and clinical significance of Wee1 in colorectal cancer.

Egeland EV, Flatmark K, Nesland JM, Flørenes VA, Mælandsmo GM, Boye K.

Tumour Biol. 2016 May 24. [Epub ahead of print]

PMID:
27220319
2.

Definition and clinical significance of tumour rupture in gastrointestinal stromal tumours of the small intestine.

Hølmebakk T, Bjerkehagen B, Boye K, Bruland Ø, Stoldt S, Sundby Hall K.

Br J Surg. 2016 Mar 14. doi: 10.1002/bjs.10104. [Epub ahead of print]

PMID:
26988241
3.

Oxaliplatin-containing Preoperative Therapy in Locally Advanced Rectal Cancer: Local Response, Toxicity and Long-term Outcome.

Dueland S, Ree AH, Grøholt KK, Saelen MG, Folkvord S, Hole KH, Seierstad T, Larsen SG, Giercksky KE, Wiig JN, Boye K, Flatmark K.

Clin Oncol (R Coll Radiol). 2016 Feb 14. pii: S0936-6555(16)00043-1. doi: 10.1016/j.clon.2016.01.014. [Epub ahead of print]

PMID:
26888115
4.

Physician perceptions of GLP-1 receptor agonists in the UK.

Matza LS, Curtis SE, Jordan JB, Adetunji O, Martin SA, Boye KS.

Curr Med Res Opin. 2016 May;32(5):857-64. doi: 10.1185/03007995.2016.1147025. Epub 2016 Feb 12.

PMID:
26807507
5.

Patient-reported outcome results in patients with type 2 diabetes treated with once-weekly dulaglutide: data from the AWARD phase III clinical trial programme.

Yu M, Van Brunt K, Varnado OJ, Boye KS.

Diabetes Obes Metab. 2016 Apr;18(4):419-24. doi: 10.1111/dom.12624. Epub 2016 Feb 4.

PMID:
26691396
6.

Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK.

Gelhorn HL, Poon JL, Davies EW, Paczkowski R, Curtis SE, Boye KS.

Patient Prefer Adherence. 2015 Nov 9;9:1611-22. doi: 10.2147/PPA.S90842. eCollection 2015.

7.

A qualitative examination of the content validity of the EQ-5D-5L in patients with type 2 diabetes.

Matza LS, Boye KS, Stewart KD, Curtis BH, Reaney M, Landrian AS.

Health Qual Life Outcomes. 2015 Dec 1;13(1):192. doi: 10.1186/s12955-015-0373-7.

8.

The time horizon matters: results of an exploratory study varying the timeframe in time trade-off and standard gamble utility elicitation.

Matza LS, Boye KS, Feeny DH, Bowman L, Johnston JA, Stewart KD, McDaniel K, Jordan J.

Eur J Health Econ. 2015 Nov 26. [Epub ahead of print]

PMID:
26611792
9.

Verification and Validation of Health Economic Models for Diabetes.

Boye KS, Lage ME, Lage MJ, Valentine WJ, Pollock RF, Saunders R.

Value Health. 2015 Nov;18(7):A702. doi: 10.1016/j.jval.2015.09.2626. Epub 2015 Oct 20. No abstract available.

PMID:
26533935
10.

Evaluating Diabetes Patients' Preferences for Profiles of Glp-1 Treatments In The United Kingdom: A Discrete Choice Experiment.

Gelhorn HL, Poon JL, Davies EW, Paczkowski R, Curtis SE, Boye KS.

Value Health. 2015 Nov;18(7):A614. doi: 10.1016/j.jval.2015.09.2133. Epub 2015 Oct 20. No abstract available.

PMID:
26533445
11.

Systematic Literature Review of Health State Utilities for Adults With Type 1 Diabetes.

Smith-Palmer J, Boye KS, Bae J, Norrbacka K, Hunt B, Valentine WJ.

Value Health. 2015 Nov;18(7):A613. doi: 10.1016/j.jval.2015.09.2131. Epub 2015 Oct 20. No abstract available.

PMID:
26533441
12.

Cost-Effectiveness of Rapid-Acting Analog Insulin for Type 1 Diabetes In The Uk Setting.

Saunders R, Boye KS, van Brunt K, Pollock RF, Valentine WJ.

Value Health. 2015 Nov;18(7):A610. doi: 10.1016/j.jval.2015.09.2114. Epub 2015 Oct 20. No abstract available.

PMID:
26533424
13.

Health State Utilities Associated With Attributes of Weekly Injection Devices for Treatment of Type 2 Diabetes.

Matza LS, Stewart KD, Davies EW, Paczkowski R, Boye KS.

Value Health. 2015 Nov;18(7):A363. doi: 10.1016/j.jval.2015.09.710. Epub 2015 Oct 20. No abstract available.

PMID:
26532052
14.

Erratum to: Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.

Fu H, Cao D, Boye KS, Curtis B, Schuster DL, Kendall DM, Ascher-Svanum H.

Diabetes Ther. 2015 Dec;6(4):651. No abstract available.

15.

Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes.

Egeland EV, Boye K, Pettersen SJ, Haugen MH, Øyjord T, Malerød L, Flatmark K, Mælandsmo GM.

Clin Exp Metastasis. 2015 Dec;32(8):755-67. doi: 10.1007/s10585-015-9742-1. Epub 2015 Sep 9.

PMID:
26349943
16.

Do 'flexicurity' Policies Work for People With Low Education and Health Problems? A Comparison of Labour Market Policies and Employment Rates in Denmark, The Netherlands, Sweden, and the United Kingdom 1990-2010.

McAllister A, Nylén L, Backhans M, Boye K, Thielen K, Whitehead M, Burström B.

Int J Health Serv. 2015;45(4):679-705. doi: 10.1177/0020731415600408. Epub 2015 Aug 13.

PMID:
26272914
17.

Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis.

Fu H, Cao D, Boye KS, Curtis B, Schuster DL, Kendall DM, Ascher-Svanum H.

Diabetes Ther. 2015 Sep;6(3):317-28. doi: 10.1007/s13300-015-0119-x. Epub 2015 Jul 5.

18.

F-18-FDG PET-CT in children and young adults with Ewing sarcoma diagnosed in Norway during 2005-2012: a national population-based study.

Johnsen B, Boye K, Rosendahl K, Biermann M, Trovik C, Aukland SM.

Clin Physiol Funct Imaging. 2015 Jun 3. doi: 10.1111/cpf.12247. [Epub ahead of print]

PMID:
26039107
19.

Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.

Cid Ruzafa J, Paczkowski R, Boye KS, Di Tanna GL, Sheetz MJ, Donaldson R, Breyer MD, Neasham D, Voelker JR.

Int J Clin Pract. 2015 Aug;69(8):871-82. doi: 10.1111/ijcp.12640. Epub 2015 May 25.

PMID:
26011029
20.

Is the current standard of care leading to cost-effective outcomes for patients with type 2 diabetes requiring insulin? A long-term health economic analysis for the UK.

Valentine WJ, Curtis BH, Pollock RF, Van Brunt K, Paczkowski R, Brändle M, Boye KS, Kendall DM.

Diabetes Res Clin Pract. 2015 Jul;109(1):95-103. doi: 10.1016/j.diabres.2015.04.023. Epub 2015 Apr 21.

PMID:
25989713
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk